September 2025 in “Journal of Dermatology Research Reviews & Reports” This study found that men aged 33 to 44 with androgenetic alopecia experienced significant hair improvement over 7 months after treatment with autologous cells using the Rigenera® system, as evaluated by HairMetrix® technology.
October 2025 in “Clinical and Experimental Dermatology” In this retrospective study, researchers reported that low-dose oral minoxidil significantly improved hair density in 60 patients with androgenetic alopecia or telogen effluvium over 4-8 months, as detected through standardized AI-powered imaging.
April 2021 in “Journal of Investigative Dermatology” This study explored the use of an AI-driven device, HairMetrix, to quantitatively assess the effects of PRP treatments on scalp health in two Caucasian women with androgenetic alopecia, reporting increases in average hair width and follicle count after one treatment.
September 2023 in “Journal of the American Academy of Dermatology” This study, examining perceptible hair density changes in androgenetic alopecia patients, found that dermatologists could accurately detect hair loss at a lower threshold than previously noted, specifically at a 22.66% relative density difference, challenging assumptions about their predictive accuracy based solely on clinical examination.
February 2025 in “Journal of Dermatological Treatment” The study explores the potential effectiveness of low-dose oral minoxidil in treating short anagen hair syndrome, suggesting it may be a viable treatment option despite the condition often resolving spontaneously with puberty.